GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ildong Pharmaceutical Co Ltd (XKRX:249420) » Definitions » Scaled Net Operating Assets

Ildong Pharmaceutical Co (XKRX:249420) Scaled Net Operating Assets : 0.48 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Ildong Pharmaceutical Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Ildong Pharmaceutical Co's operating assets for the quarter that ended in Sep. 2024 was ₩529,040 Mil. Ildong Pharmaceutical Co's operating liabilities for the quarter that ended in Sep. 2024 was ₩238,143 Mil. Ildong Pharmaceutical Co's Total Assets for the quarter that ended in Jun. 2024 was ₩604,712 Mil. Therefore, Ildong Pharmaceutical Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.48.


Ildong Pharmaceutical Co Scaled Net Operating Assets Historical Data

The historical data trend for Ildong Pharmaceutical Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ildong Pharmaceutical Co Scaled Net Operating Assets Chart

Ildong Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.58 0.55 0.38 0.46 0.47

Ildong Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.52 0.51 0.52 0.48

Competitive Comparison of Ildong Pharmaceutical Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Ildong Pharmaceutical Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ildong Pharmaceutical Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ildong Pharmaceutical Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Ildong Pharmaceutical Co's Scaled Net Operating Assets falls into.



Ildong Pharmaceutical Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Ildong Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(529981.844-224269.28)/655810.214
=0.47

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=611260.857 - 81279.013
=529981.844

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=436995.279 - 31479.481 - 181246.518
=224269.28

Ildong Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(529039.749-238143.444)/604711.849
=0.48

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=590460.96 - 61421.211
=529039.749

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=433028.667 - 75209.411 - 119675.812
=238143.444

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ildong Pharmaceutical Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Ildong Pharmaceutical Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Ildong Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
2 Baumoe-ro 27-gil, Seocho-gu, Seoul, KOR, 137-733
Ildong Pharmaceutical Co Ltd is a Korean company which is engaged in manufacturing pharmaceutical products. Its product portfolio includes generic drugs and specialty drugs, such as vitamin supplements, digestive medications, vascular medications, probiotics, topical applications, antihistamines, antipyretics, analgesics, respiratory medications, endocrine medications, psycho-neurological medications, dermatological medications, urologic medications, antibiotics and others. The company also provides raw materials such as synthesizes, probiotics and others.

Ildong Pharmaceutical Co Headlines

No Headlines